Evidence map›Paper›PMID 7538451›Full record

ArticleCell and tissue research1995

c-kit-dependent development of interstitial cells and electrical activity in the murine gastrointestinal tract.

S Torihashi, S M Ward, S Nishikawa, K Nishi, S Kobayashi, K M Sanders

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Cell and tissue research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04557215 (Evaluation of the Efficacy and Safety of Rifaximin in Combination With N-acetylcysteine), which is not on this map. Cited by 153 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04557215 phase1 / phase2completednot on this mapstarted 2020, after this paper: background citation

Evaluation of the Efficacy and Safety of Rifaximin in Combination With N-acetylcysteine (NAC) in Adult Patients With Irritable Bowel Syndrome With Diarrhea

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2020 to 2022Enrolled45ConditionsIrritable Bowel Syndrome With DiarrheaArmsRifaximin, N-acetylcysteine, Placebo
3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 1 synthesis or guideline pooled it, 398 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Disruption of gastrointestinal PDGFRαAmerican journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  4. Pharmaceutical biology · 2025
    Article
  5. Article
  6. Article
  7. Functional roles of interstitial cells of Cajal in the GI tract of rats.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Article
  8. Effects ofWorld journal of gastroenterology · 2025
    Article
  9. Review
  10. CaPhysiological reviews · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Interstitial cells of Cajal in gastrointestinal inflammatory diseases.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. CaAdvances in experimental medicine and biology · 2022
    Article

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

S TorihashiDepartment of Physiology, University of Nevada School of Medicine, Reno 89557.
S M Ward
S Nishikawa
K Nishi
S Kobayashi
K M Sanders
University of Nevada, Reno · USKumamoto University · JPKyoto University · JPNagoya University · JP

Funding

Tissue, Cell and Tissue Culture CoreP01DK041315 · NIDDK · UNIVERSITY OF NEVADA RENO · PI WARD, SEAN M · 1989 to 2018
$26.3M
NIDDK NIH HHS P01 DK41315
6 · The paper itself

Abstract

In vivo injection of a neutralizing, monoclonal antibody (ACK2) to the receptor tyrosine kinase (c-kit) disrupts the normal motility patterns of the mouse small intestine. Immunohistochemical studies showed that cells expressing c-kit-like immunoreactivity (c-kit-LI) decreased in numbers in response to ACK2, but the identity of these cells is unknown. We investigated the identity and development of the cells that express c-kit-LI in the mouse small intestine and colon. Cells in the region of the myenteric plexus and deep muscular plexus of the small intestine and in the subserosa, in the myenteric plexus region, within the circular and longitudinal muscle layers, and along the submucosal surface of the circular muscle in the colon were labeled with ACK2. The distribution of cells that express c-kit-LI was the same as that of interstitial cells (ICs). In whole-mount preparations cells with c-kit-LI were interconnected, forming a network similar to the network formed by cells that stained with methylene blue, which has been used as a marker for ICs in the mouse gastrointestinal tract. Immunocytochemistry verified that ICs were labeled with ACK2. Multiple injections of animals with ACK2 between days 0 and 8 post partum (pp) caused a dramatic reduction in the number of ICs compared to control animals. From an ultrastructural point of view, the proliferation and development appeared to be suppressed in some classes of ICs, while others displayed an altered course of development. Functional studies showed that the decrease in ICs was accompanied by a loss of electrical rhythmicity in the small intestine and reduced neural responses in the small bowel and colon. Morphological experiments showed that c-kit-positive cells are ICs, and physiological evidence reinforced the concept that ICs are involved in generation of rhythmicity and translation of neural inputs in gastrointestinal smooth muscles. Controlling the development of ICs provides a powerful new tool for the investigation of the physiological role of these cells.

Indexed as

AnimalsAnimals, NewbornAntibodies, MonoclonalColonDigestive SystemDigestive System Physiological PhenomenaGastrointestinal MotilityIleumMethylene BlueMiceMice, Inbred BALB CMicroscopy, ElectronMuscle, SmoothMyenteric PlexusNeural ConductionOrganellesAntibodies, MonoclonalMethylene BlueProto-Oncogene ProteinsProto-Oncogene Proteins c-kitReceptor Protein-Tyrosine KinasesReceptors, Colony-Stimulating FactorTolonium Chloride

Identifiers

PMID7538451
OpenAlexW2077442056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.